Gene · 1052
Papers3,093
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 3,093
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Metabolomic, Lipidomic, Transcriptomic, and Metagenomic Analyses in Mice Exposed to PFOS and Fed Soluble and Insoluble Dietary Fibers. | Environ Health Perspect | 2022 | 36331819 | PubTator, text mining | PubMed |
| The P300 event related potential predicts phonological working memory skills in school-aged children. | Front Psychol | 2022 | 36312112 | PubTator, text mining | PubMed |
| CCAAT/Enhancer-Binding Proteins in Fibrosis: Complex Roles Beyond Conventional Understanding. | Research (Wash D C) | 2022 | 36299447 | PubTator, text mining | PubMed |
| PRKCE non-coding variants influence on transcription as well as translation of its gene. | RNA Biol | 2022 | 36299231 | PubTator, text mining | PubMed |
| Pharmacological Properties of Trichostatin A, Focusing on the Anticancer Potential: A Comprehensive Review. | Pharmaceuticals (Basel) | 2022 | 36297347 | PubTator, text mining | PubMed |
| Identification of Prognostic Gene Signatures by Developing a scRNA-Seq-Based Integration Approach to Predict Recurrence and Chemotherapy Benefit in Stage II-III Colorectal Cancer. | Int J Mol Sci | 2022 | 36293319 | PubTator, text mining | PubMed |
| Bioinformatics and Experimental Analyses Reveal MAP4K4 as a Potential Marker for Gastric Cancer. | Genes (Basel) | 2022 | 36292671 | PubTator, text mining | PubMed |
| Therapeutic Strategies for Restoring Perturbed Corneal Epithelial Homeostasis in Limbal Stem Cell Deficiency: Current Trends and Future Directions. | Cells | 2022 | 36291115 | PubTator, text mining | PubMed |
| PPAR-γ Partial Agonists in Disease-Fate Decision with Special Reference to Cancer. | Cells | 2022 | 36291082 | PubTator, text mining | PubMed |
| Nanomaterial-assisted CRISPR gene-engineering - A hallmark for triple-negative breast cancer therapeutics advancement. | Mater Today Bio | 2022 | 36267139 | PubTator, text mining | PubMed |
| The role of lung macrophages in acute respiratory distress syndrome. | Inflamm Res | 2022 | 36264361 | PubTator, text mining | PubMed |
| Maternal rodent exposure to di-(2-ethylhexyl) phthalate decreases muscle mass in the offspring by increasing myostatin. | J Cachexia Sarcopenia Muscle | 2022 | 36263449 | PubTator, text mining | PubMed |
| Distinct responses of newly identified monocyte subsets to advanced gastrointestinal cancer and COVID-19. | Front Immunol | 2022 | 36263038 | PubTator, text mining | PubMed |
| miR-aculous new avenues for cancer immunotherapy. | Front Immunol | 2022 | 36248881 | PubTator, text mining | PubMed |
| CELF1 represses Doublesex1 expression via its 5' UTR in the crustacean Daphnia magna. | PLoS One | 2022 | 36240182 | PubTator, text mining | PubMed |
| Alzheimer's disease large-scale gene expression portrait identifies exercise as the top theoretical treatment. | Sci Rep | 2022 | 36229643 | PubTator, text mining | PubMed |
| Single-cell sequencing of PBMC characterizes the altered transcriptomic landscape of classical monocytes in BNT162b2-induced myocarditis. | Front Immunol | 2022 | 36225942 | PubTator, text mining | PubMed |
| Deciphering transcriptome alterations in bone marrow hematopoiesis at single-cell resolution in immune thrombocytopenia. | Signal Transduct Target Ther | 2022 | 36202780 | PubTator, text mining | PubMed |
| Aging compromises human islet beta cell function and identity by decreasing transcription factor activity and inducing ER stress. | Sci Adv | 2022 | 36197983 | PubTator, text mining | PubMed |
| Autoantibodies in the pathogenesis of idiopathic inflammatory myopathies: Does the endoplasmic reticulum stress response have a role? | Front Immunol | 2022 | 36189221 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1052/papers?page=25